2EyesVision, with the slogan "Seeing is Believing," is revolutionizing the ophthalmology industry with its innovative and disruptive products. Founded in 2015 in Spain, the startup is dedicated to creating and commercializing cutting-edge ophthalmic technologies, aiming to provide high-quality and personalized solutions to eye care professionals and patients. The company's flagship technology, SimVis Gekko, demonstrates its commitment to challenging the global premium ophthalmology market and reshaping the future of visual health. Recently, on 11 April 2023, 2EyesVision secured a noteworthy €538.00K Series A investment from Bullnet Capital and INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA. With its firm grip on innovation and a clear vision for the future, 2EyesVision carries significant potential within the Health Care industry for prospective investors.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | €538.00K | 2 | INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA | 11 Apr 2023 |
Grant | €76.00K | - | 28 Dec 2022 | |
Debt Financing | €199.00K | - | 28 Dec 2022 | |
Grant | €112.00K | - | 13 Oct 2022 | |
Series A | €555.90K | 2 | INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA | 28 Jul 2022 |
No recent news or press coverage available for 2EyesVision.